Commentary · 21 Feb 2026
Conference abstractPublished 26 Jun 2017
Cancer stem cells in renal clear cell carcinoma
Gillies McIndoe Research Institute, New Zealand Wellington Regional Hospital, New Zealand Hutt Hospital, Wellington, New Zealand
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction & Aim: Renal cell carcinoma is the ninth most common cancer worldwide, with renal clear cell carcinoma (RCCC) making up 80-85% of these. Current treatment for RCCC involves nephrectomy with 40% developing a recurrence with an overall 5-year survival rate of 10%. This study aimed to characterise these CSCs. Methodology: DAB immunohistochemical (IHC) staining was performed on six CRCLM samples for CSC markers OCT4, SOX2, NANOG, c-Myc and KLF4. Immunofluorescent (IF) IHC staining was performed to investigate the co-expression of two markers. NanoString and in situ hybridisation (ISH) mRNA analyses were performed for transcriptional expression. Cell counting was performed on the IHC and ISH stains and the t-tests for statistical analysis. Results: DAB IHC staining demonstrated the expression of all 5 CSC markers in RCCC, and supported by NanoString and ISH analyses. IF IHC staining demonstrated the co-expression of OCT4 in a proportion of the SOX2+/NANOG+/KLF4+ populations. Furthermore the co-expression of KLF4 was also demonstrated in a proportion of the SOX2+/NANOG+/KLF4+ population. Cell counting demonstrated a high abundance of NANOG (86%), SOX2 (83%) and c-Myc (80%), with lower counts for KLF4 (15%) and OCT4 (8%). Conclusion: This study shows a range of CSC sub populations within RCCC with a less abundant OCT4+/c-Myc+/SOX2+/NANOG+ sub population and a KLF4+/c-Myc+/SOX2+/NANOG+, this is supported by relatively low abundance of OCT4+ and KLF4+ cells. These novel findings support the presence of potentially two subpopulations of CSCs within RCCC, although equally as likely is that the OCT4+ cells are a subset of the KLF4+/c-Myc+/SOX2+/NANOG+ cells.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Tinte Itinteang”
- BylineArticles whose byline prints “Reuben Cane”
- BylineArticles whose byline prints “Andrew Kennedy-Smith”
- BylineArticles whose byline prints “Helen D Brasch”
- BylineArticles whose byline prints “Reginald Marsh”
- BylineArticles whose byline prints “Swee T Tan”
